Ray Dalio Gsk PLC Transaction History

Bridgewater Associates, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $275,007 - $312,415	-6,540 Reduced 6.66%	91,661 $3.99 Million
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $215,793 - $256,077	5,364 Added 5.78%	98,201 $4.28 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $1.04 Million - $1.21 Million	-26,803 Reduced 22.4%	92,837 $4.09 Million
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $244,454 - $271,994	6,302 Added 5.56%	119,640 $4.57 Million
Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $4.14 Million - $4.7 Million	113,338 New	113,338 $4.51 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.